Updates & Insights
Driving breakthrough discoveries for better healthcare outcomes.
Explore SPARC’s work in action, including panel discussions, articles, and more.
CAMK2-Related Neurodevelopmental Disorders: A Giving Smarter Guide
Schizophrenia Research and Care: Assessment of Challenges and Opportunities
SPARC conducted an extensive literature review with insights from over 70 experts, to find five areas where philanthropy can drive meaningful progress in schizophrenia research and care.
 Uterine Leiomyosarcoma: A Giving Smarter GuideÂ
SPARC analyzed the scientific and clinical landscape of uLMS to identify unmet needs and opportunities where philanthropy can drive innovation and accelerate progress.
Milken Institute Global Conference 2025 panel: Fact or Fiction: Fostering Trust in Science
Public trust in science is vital yet threatened by misinformation and low health literacy. This session explores cross-sector strategies to rebuild confidence through transparency and effective communication.
Milken Institute Global Conference 2025 panel: Advancing Paths to Precision Brain Health
This panel at the 2025 Milken Institute Global Conference discusses innovative techniques to diagnose and treat neurological conditions, including leveraging AI and big data.
Milken Institute Global Conference 2025 panel: Expanding Solutions to Improve Mental Health
Mental health care requires bold, cross-sector collaboration that extends beyond traditional systems. This panel explores how collective action can reduce stigma, expand access, and drive scalable, transformative solutions for mental health worldwide.
How Philanthropy Can Support a Community-Centered Biomedical Research Ecosystem to Achieve Health Equity
Health equity ensures everyone has a fair chance at good health, yet systemic barriers in research leave many communities behind. Philanthropy can help close these gaps by investing in inclusive research, community engagement, and workforce diversity.
The Value of Collaboration in Rare Disease Research
Childhood brain cancers are among the rarest and most difficult to treat, but new models of collaboration are changing what’s possible. This article explores how philanthropy, advocacy, and cross-sector partnerships are breaking down barriers and accelerating progress toward better treatments.
BD² 2024 Milestone Report
In 2024, major strides were made in accelerating bipolar disorder research. This report highlights BD²’s progress and the growing collaboration aimed at improving outcomes for people living with the condition.
Milken SPARC, partners commit $70 million to underinvested diseases
SPARC, in collaboration with its philanthropic partners, has announced commitments totaling $70 million to bolster research into historically underinvested diseases.
Milken Institute Future of Health Summit 2024 panel: Catalysts of Change: Philanthropy, Advocacy, and Innovation in Rare Disease Research
Collaboration across the rare disease community has driven major breakthroughs in diagnosis and treatment. Innovative, data-driven approaches pioneered in this field are now shaping a new model for medical research—one that could improve outcomes and reduce costs across all diseases.